Ketoprofen
1 NDC across 1 manufacturer|1 Generic,0 Brand
Ketoprofen is used to treat rheumatoid arthritis, dysmenorrhea and osteoarthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 9, 1986, and the first generic was approved Dec 22, 1992. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Ketoprofen across 2,274 claims for 752 beneficiaries.
Ketoprofen is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $6.46 to $6.46 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$6.46 – $6.46
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Mylan Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing KETOPROFEN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KETOPROFEN ER 200 MG CAPSULE | $6.4618 per EA | — |
Frequently Asked Questions
What is Ketoprofen used to treat?
Ketoprofen is used to treat rheumatoid arthritis, dysmenorrhea and osteoarthritis, per the National Library of Medicine's MED-RT classification.
When did Ketoprofen become available as a generic?
FDA approved the first generic Ketoprofen (ANDA) on Dec 22, 1992. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ketoprofen?
In 2024, Medicare Part D spent $2 million on Ketoprofen across 2,274 claims for 752 beneficiaries.
How many Ketoprofen products are on the market?
The Ketoprofen drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Ketoprofen?
NADAC reference prices for Ketoprofen range from $6.4618 to $6.4618 per EA.
Which manufacturers make Ketoprofen?
1 manufacturer lists Ketoprofen in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (1).